Granahan Investment Management - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,075,979
-44.3%
355,360
+23.0%
0.14%
-35.6%
Q2 2023$7,312,742
-6.7%
288,927
+18.7%
0.22%
-5.9%
Q1 2023$7,841,911
+22.0%
243,462
-30.1%
0.24%
+21.9%
Q4 2022$6,425,261
-2.8%
348,064
+42.1%
0.20%
-9.3%
Q3 2022$6,613,000
+113.9%
244,917
+9.5%
0.22%
+103.8%
Q2 2022$3,091,000
-2.0%
223,631
+38.3%
0.11%
+35.9%
Q1 2022$3,153,000
-10.8%
161,695
-25.3%
0.08%
+6.8%
Q4 2021$3,533,000
-1.1%
216,497
+68.8%
0.07%
+7.4%
Q3 2021$3,573,000128,2390.07%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 5,228,609$59,972,1455.67%
Essex Woodlands Management, Inc. 457,085$5,242,7654.62%
Ghost Tree Capital, LLC 350,000$4,014,5001.32%
AlphaCentric Advisors LLC 190,000$2,179,3001.24%
Sio Capital Management, LLC 342,477$3,928,2111.22%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 288,726$3,308,8001.12%
Rubric Capital Management LP 1,600,000$18,352,0000.69%
RICE HALL JAMES & ASSOCIATES, LLC 683,937$7,844,7570.50%
Rhenman & Partners Asset Management AB 361,679$4,148,4580.45%
Polar Capital Holdings Plc 4,160,311$47,718,7670.35%
View complete list of REVANCE THERAPEUTICS INC shareholders